Why the study?
Clinical factors associated with termination of pregnancy recommendations after prenatal diagnosis of congenital heart disease in a multidisciplinary fetal council model remained to be evaluated.
In a multidisciplinary fetal council model, recommendations for termination of pregnancy following prenatal diagnosis of congenital heart disease are primarily driven by cardiac severity and gestational age at diagnosis.
Answers are grounded in this paper and cite their sources.
Weigh cardiac severity and diagnosis timing in fetal CHD TOP counseling; extends multidisciplinary cohort data on key decision drivers.
Objective: To evaluate clinical factors associated with termination of pregnancy (TOP) recommendations following prenatal diagnosis of congenital heart disease (CHD) within a multidisciplinary fetal council model. Methods: This retrospective cohort study included 146 fetuses with prenatally diagnosed CHD discussed in a tertiary referral center fetal council between October 2023 and December 2025. The primary outcome was council-issued recommendation for TOP (yes/no). Variables included gestational age (GA) at diagnosis, cardiac severity (Davey scale grouped as low, moderate, high), extracardiac anomalies, fetal growth restriction (FGR), and genetic evaluation/results. Group comparisons were performed using Mann–Whitney U and χ2 tests. Independent associations were assessed using binary logistic regression. A subgroup analysis was conducted in isolated CHD cases (no extracardiac structural anomalies). Results: A total of 146 fetuses with prenatal CHD were included in the analysis. TOP was recommended in 71 cases (48.6%). GA at diagnosis did not differ between groups when analyzed continuously; however, categorical GA showed significant differences, with earlier diagnoses more frequent among TOP-recommended cases. Cardiac severity distribution differed significantly between groups. In multivariable analysis, GA at diagnosis and cardiac severity were independently associated with TOP recommendation. Compared with <20 weeks, diagnosis at 20–23+6 weeks (OR 17.96, 95% CI 3.50–92.22) and ≥24 weeks (OR 3.92, 95% CI 1.53–10.06) increased the odds of TOP recommendation. Relative to high severity, moderate (OR 0.23, 95% CI 0.07–0.72) and low severity (OR 0.20, 95% CI 0.08–0.50) were associated with lower odds of TOP recommendation. Extracardiac anomalies, genetic findings, and FGR were not independently associated after adjustment. Similar patterns were observed in isolated CHD cases. Conclusions: In a multidisciplinary prenatal counseling setting, TOP recommendations after prenatal CHD diagnosis were primarily driven by cardiac severity and GA at diagnosis, rather than extracardiac or genetic findings alone.
No takes yet. Share an insight, caveat, or question.
Arzik et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: